This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

UPDATE: Appeal Of Lawsuit By Former Chief Executive Officer- Reinstated; And Sanctions Order Vacated

PHILADELPHIA, March 23 /PRNewswire/ -- The Superior Court of Pennsylvania has reinstated an appeal filed by John R. DePhillipo, former Chief Executive Officer of GeneLink Biosciences, (GNLK:OB) and his wife Maria. The appeal had been dismissed by an order from the same court on February 18, 2010. The Superior Court also ordered " The Prothonotary to list the matter for argument before the first available panel."

Originally, DePhillipo and his wife filed suit against GeneLink and GeneWize, a wholly owned Subsidiary of GeneLink, claiming they were induced to settle an Atlantic County, N.J. law suit by fraud. The complaint alleged that GeneLink's attorney made false representations to John DePhillipo, his lawyer and the trial judge relative to the alleged poor economic well being of GeneLink. ("Defendant GeneLink, Inc. was in such dire financial straits that he didn't know how they were able to pay his attorneys fees.")

Within an hour after the DePhillipos settled the Atlantic County case, GeneLink officers filed a press release revealing, for the first time, the existence of their wholly owned subsidiary, GeneWize. They also added that GeneWize had sold approximately 250 presidential founder memberships for One Thousand ($1000.00) dollars and over 4,000 GeneWize dealerships for Five Hundred ($500.00)

The Common Pleas Court Philadelphia judge dismissed the case ruling that GeneLink's lawyer was only puffing. The appeal to the Superior Court followed.

SOURCE GUSTINE J. PELAGATTI & ASSOCIATES

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
GNLK $0.00 0.00%
AAPL $128.95 0.00%
FB $78.99 0.00%
GOOG $537.90 0.00%
TSLA $226.03 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs